Dimensional thinking in psychiatry in the era of the Research Domain Criteria (RDoC)
Open accessThe DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
The biological mechanisms underlying psychiatric diagnoses are not well defined. Clinical diagnosis based on categorical systems exhibit high levels of heterogeneity and co-morbidity. The Research Domain Criteria (RDoC) attempts to reconceptualize psychiatric disorders into transdiagnostic functional dimensional constructs based on neurobiological measures and observable behaviour. By understanding the underlying neurobiology and pathophysiology of the relevant processes, the RDoC aims to advance biomarker development for disease prediction and treatment response. This important evolving dimensional framework must also consider environmental factors. Emerging evidence suggests that gut microbes (microbiome) play a physiological role in brain diseases by modulating neuroimmune, neuroendocrine and neural signalling pathways between the gut and the brain. The integration of the gut microbiome signature as an additional dimensional component of the RDoC may enhance precision psychiatry.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The price of innovation: new estimates of drug development costs
DiMasi, J. A., Hansen, R. W., & Grabowski, H. G. (2003) · Journal of Health Economics · doi:10.1016/s0167-6296(02)00126-1 · Cited by 4,265
(2013) · The Lancet · doi:10.1016/s0140-6736(12)62129-1 · Cited by 3,010 · cited 1×
“The overlap of presumed distinct psychiatric diagnoses have been demonstrated at the genetic (Craddock & Owen, 2010; Smoller et al. 2013), molecular (Krishnan & Nestler, 2010), cellular (Swardfager et al. 2016), brain circuit (Hulshoff Pol et al. 2012; Drysdale et al. 2017), pathophysiology (Garn…”
BackgroundResting-state connectivity biomarkers define neurophysiological subtypes of depression
Drysdale, A. T., Grosenick, L., Downar, J., Dunlop, K., Mansouri, F., Meng, Y., Fetcho, R. N., Zebley, B., Oathes, D. J., Etkin, A., et al. (2017) · Nature Medicine · doi:10.1038/nm.4246 · Cited by 2,170 · cited 1×
“…been demonstrated at the genetic (Craddock & Owen, 2010; Smoller et al. 2013), molecular (Krishnan & Nestler, 2010), cellular (Swardfager et al. 2016), brain circuit (Hulshoff Pol et al. 2012; Drysdale et al. 2017), pathophysiology (Garn et al. 2016) and psychological levels (Catalan et al. 2016).”
BackgroundKelly, J. R., Borre, Y., O' Brien, C., Patterson, E., El Aidy, S., Deane, J., Kennedy, P. J., Beers, S., Scott, K., Moloney, G., et al. (2016) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2016.07.019 · Cited by 1,683
Self-citationGut microbes and the brain: paradigm shift in neuroscience
Mayer, E. A., Knight, R., Mazmanian, S. K., Cryan, J. F., & Tillisch, K. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.3299-14.2014 · Cited by 1,033
Self-citationKapur, S., Phillips, A. G., & Insel, T. R. (2012) · Molecular Psychiatry · doi:10.1038/mp.2012.105 · Cited by 980 · cited 2×
“…to better align pre-clinical and clinical studies to build a common framework of comparable neurobiological abnormalities, for example, to help stratify subgroups of patients on the basis of similar pathophysiology, rather than diagnostic categories based on phenomenology (Kapur et al. 2012).”
BackgroundInsel, T. R., & Cuthbert, B. N. (2015) · Science · doi:10.1126/science.aab2358 · Cited by 840
Cross-trial prediction of treatment outcome in depression: a machine learning approach
Chekroud, A. M., Zotti, R. J., Shehzad, Z., Gueorguieva, R., Johnson, M. K., Trivedi, M. H., Cannon, T. D., Krystal, J. H., & Corlett, P. R. (2016) · The Lancet Psychiatry · doi:10.1016/s2215-0366(15)00471-x · Cited by 676 · cited 3×
“2017) and the Sequenced Treatment Alternatives to Relieve Depression (Chekroud et al. 2016; Chekroud et al. 2017) have now been re-analysed using a dimensional approach, in an effort to improve tools necessary to implement stratification.”
MethodThe Kraepelinian dichotomy – going, going … but still not gone
Craddock, N., & Owen, M. J. (2010) · British Journal of Psychiatry · doi:10.1192/bjp.bp.109.073429 · Cited by 587
The heterogeneity of “major depression”
GOLDBERG, D. (2011) · World Psychiatry · doi:10.1002/j.2051-5545.2011.tb00061.x · Cited by 335 · cited 1×
“However, given the complexity of the brain, categorical diagnoses also render high levels of heterogeneity in terms of symptom profile, causality, psychopathology and treatment response (Trivedi et al. 2006; Baca-Garcia et al. 2007; Goldberg, 2011).”
Background
Cited by
Perturbations in Gut Microbiota Composition in Psychiatric Disorders: A Review and Meta-analysis
Nikolova, V. L., Smith, M. R. B., Hall, L. J., Cleare, A. J., Stone, J. M., & Young, A. H. (2021) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2021.2573 · Cited by 731
Cross talk: the microbiota and neurodevelopmental disorders
Kelly, J. R., Minuto, C., Cryan, J. F., Clarke, G., & Dinan, T. G. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00490 · Cited by 271
Self-citationPsychedelic therapy's transdiagnostic effects: A research domain criteria (RDoC) perspective
Kelly, J. R., Gillan, C. M., Prenderville, J., Kelly, C., Harkin, A., Clarke, G., & O'Keane, V. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.800072 · Cited by 69
Self-citationKelly, J. R., Keane, V. O., Cryan, J. F., Clarke, G., & Dinan, T. G. (2019) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2019.04.006 · Cited by 65
Self-citationObsessive-compulsive symptoms in schizophrenia: an up-to-date review of literature
Tezenas du Montcel, C., Pelissolo, A., Schürhoff, F., & Pignon, B. (2019) · Current Psychiatry Reports · doi:10.1007/s11920-019-1051-y · Cited by 61
Metadata
- Authors
- Kelly, J. R., Clarke, G., Cryan, J. F., & Dinan, T. G.
- Venue
- Irish Journal of Psychological Medicine
- Publisher
- Cambridge University Press (CUP)
- Published
- 2017-04-05
- Volume
- 35
- Issue
- 2
- Pages
- 89-94
- ISSN
- 0790-9667 (ISSN-L)
- 2051-6967
- OpenAlex
- W2605025653
- Cited by
- 39
- References
- 16
- FWCI
- 29.57
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.